These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17147488)

  • 41. Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss.
    Aguirre JI; Plotkin LI; Stewart SA; Weinstein RS; Parfitt AM; Manolagas SC; Bellido T
    J Bone Miner Res; 2006 Apr; 21(4):605-15. PubMed ID: 16598381
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of sex steroid receptor specificity in the regulation of skeletal metabolism.
    Tözüm TF; Oppenlander ME; Koh-Paige AJ; Robins DM; McCauley LK
    Calcif Tissue Int; 2004 Jul; 75(1):60-70. PubMed ID: 15037970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased bone formation in mice lacking apolipoprotein E.
    Schilling AF; Schinke T; Münch C; Gebauer M; Niemeier A; Priemel M; Streichert T; Rueger JM; Amling M
    J Bone Miner Res; 2005 Feb; 20(2):274-82. PubMed ID: 15647822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor.
    Wu CT; Altuwaijri S; Ricke WA; Huang SP; Yeh S; Zhang C; Niu Y; Tsai MY; Chang C
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12679-84. PubMed ID: 17652515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
    Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
    J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Androgen function on skeletal tissues: analysis of androgen receptor-deficient mice].
    Kawano H; Kawaguchi H
    Clin Calcium; 2006 Mar; 16(3):455-60. PubMed ID: 16508128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
    Hofbauer LC; Hicok KC; Khosla S
    J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
    Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
    Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency.
    Mohan S; Kapoor A; Singgih A; Zhang Z; Taylor T; Yu H; Chadwick RB; Chung YS; Donahue LR; Rosen C; Crawford GC; Wergedal J; Baylink DJ
    J Bone Miner Res; 2005 Sep; 20(9):1597-610. PubMed ID: 16059632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgens and the skeleton.
    Lindberg MK; Vandenput L; Movèrare Skrtic S; Vanderschueren D; Boonen S; Bouillon R; Ohlsson C
    Minerva Endocrinol; 2005 Mar; 30(1):15-25. PubMed ID: 15877010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The androgen receptor has no direct antiresorptive actions in mouse osteoclasts.
    Sinnesael M; Jardi F; Deboel L; Laurent MR; Dubois V; Zajac JD; Davey RA; Carmeliet G; Claessens F; Vanderschueren D
    Mol Cell Endocrinol; 2015 Aug; 411():198-206. PubMed ID: 25958043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes.
    Wiren KM; Zhang XW; Olson DA; Turner RT; Iwaniec UT
    Bone; 2012 Nov; 51(5):835-46. PubMed ID: 22910580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide.
    Schinke T; Liese S; Priemel M; Haberland M; Schilling AF; Catala-Lehnen P; Blicharski D; Rueger JM; Gagel RF; Emeson RB; Amling M
    J Bone Miner Res; 2004 Dec; 19(12):2049-56. PubMed ID: 15537449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of estrogen receptor α in bone-forming cells induces bone loss in female mice.
    Määttä JA; Büki KG; Gu G; Alanne MH; Vääräniemi J; Liljenbäck H; Poutanen M; Härkönen P; Väänänen K
    FASEB J; 2013 Feb; 27(2):478-88. PubMed ID: 23073829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skeletal characterization of an osteoblast-specific vitamin D receptor transgenic (ObVDR-B6) mouse model.
    Triliana R; Lam NN; Sawyer RK; Atkins GJ; Morris HA; Anderson PH
    J Steroid Biochem Mol Biol; 2016 Nov; 164():331-336. PubMed ID: 26343450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High bone mass in mice expressing a mutant LRP5 gene.
    Babij P; Zhao W; Small C; Kharode Y; Yaworsky PJ; Bouxsein ML; Reddy PS; Bodine PV; Robinson JA; Bhat B; Marzolf J; Moran RA; Bex F
    J Bone Miner Res; 2003 Jun; 18(6):960-74. PubMed ID: 12817748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass.
    Geoffroy V; Marty-Morieux C; Le Goupil N; Clement-Lacroix P; Terraz C; Frain M; Roux S; Rossert J; de Vernejoul MC
    J Bone Miner Res; 2004 May; 19(5):811-22. PubMed ID: 15068505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation.
    Kawelke N; Bentmann A; Hackl N; Hager HD; Feick P; Geursen A; Singer MV; Nakchbandi IA
    J Bone Miner Res; 2008 Aug; 23(8):1278-86. PubMed ID: 18348696
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton.
    Wiren KM; Semirale AA; Zhang XW; Woo A; Tommasini SM; Price C; Schaffler MB; Jepsen KJ
    Bone; 2008 Sep; 43(3):440-51. PubMed ID: 18595795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.